タネズマブ試験の被験者のうち、膝、股関節、または肩の人工関節置換術を受けた被験者を対象とした長期観察研究

基本情報

NCT ID

NCT02674386

ステータス

完了

試験のフェーズ

第3相

試験タイプ

介入

目標被験者数

154

治験依頼者名

Pfizer

概要

A4091064 is a multicenter, long-term observational study of subjects from tanezumab interventional studies (regardless of treatment group) who undergo a total knee, hip or shoulder replacement during participation in the study. The study is designed with a total duration of subject follow-up of 24 weeks after the total joint replacement surgery. There will be two methods of data collection utilized in this study: interview by site staff via the telephone and interactive web-response system (or paper if the subject has no access to the internet).

対象疾患

介入

依頼者（Sponsor）

実施施設 (5)